A detailed history of Stokes Family Office, LLC transactions in Inogen Inc stock. As of the latest transaction made, Stokes Family Office, LLC holds 126,785 shares of INGN stock, worth $1.2 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
126,785
Previous 113,985 11.23%
Holding current value
$1.2 Million
Previous $926,000 32.72%
% of portfolio
0.14%
Previous 0.11%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$7.67 - $12.98 $98,176 - $166,144
12,800 Added 11.23%
126,785 $1.23 Million
Q2 2024

Jul 05, 2024

BUY
$6.3 - $8.95 $444,150 - $630,975
70,500 Added 162.12%
113,985 $926,000
Q1 2024

May 06, 2024

BUY
$5.26 - $10.15 $228,731 - $441,372
43,485 New
43,485 $350,000

Others Institutions Holding INGN

About Inogen Inc


  • Ticker INGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 22,866,500
  • Market Cap $216M
  • Description
  • Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respirat...
More about INGN
Track This Portfolio

Track Stokes Family Office, LLC Portfolio

Follow Stokes Family Office, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stokes Family Office, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stokes Family Office, LLC with notifications on news.